Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 357301 - 357320 out of 498429 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Poland | (L01EX01) sunitinib (adm: O) | Sunitinib MSN, kaps. twarde, 50 mg | 28 szt., 50 mg , 28 kaps. w blistrze perforowanym | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | MSNLabsEuropeLimited |
Poland | (L01EX01) sunitinib (adm: O) | Sunitinib Sandoz, kaps. twarde, 50 mg | 28 szt., 50 mg , 28 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | SandozGmbH |
Poland | (L01EX01) sunitinib (adm: O) | Sunitinib Vipharm, kaps. twarde, 50 mg | 30 szt., 50 mg , 30 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A. |
Poland | (L01EX02) sorafenib (adm: O) | Sorafenib Zentiva, tabl. powl., 200 mg | 112 szt., 200 mg , 112 tabl. w blistrze perforowanym | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
Poland | (L01EX05) regorafenib (adm: O) | Stivarga, tabl. powl., 40 mg | 84 szt., 40 mg , 3 butelki 28 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | BayerAG |
Poland | (L01EX19) ripretinib (adm: O) | Qinlock, tabl., 50 mg | 90 szt. | Wholesale price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | n/a |
Poland | (L01FC01) daratumumab | Darzalex, roztwór do wstrzykiwań, 1800 mg (120 mg/ml) | 1 fiol. 15 ml, 1800 mg (120 mg/ml) , 1 fiol. 15 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V. |
Poland | (L01FC02) isatuximab | Sarclisa, koncentrat do sporządzania roztworu do infuzji, 20 mg/ml | 1 fiol. po 25 ml, 20 mg/ml , 1 fiol. 25 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiWinthropIndustrie |
Poland | (L01FC02) isatuximab | Sarclisa, koncentrat do sporządzania roztworu do infuzji, 20 mg/ml | 1 fiol. po 5 ml, 20 mg/ml , 1 fiol. 5 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiWinthropIndustrie |
Poland | (L01FX12) tafasitamab | Minjuvi, proszek do sporządzania koncentratu roztworu do infuzji, 200 mg | 1 fiol. proszku, 200 mg , 1 fiol. 200 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | IncyteBiosciencesDistributionB.V. |
Poland | (L01XG01) bortezomib | Bortezomib Eugia, proszek do sporządzania roztworu do wstrzykiwań, 3,5 mg | 1 fiol., 3,5 mg , 1 fiol. 3,5 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | EugiaPharma(Malta)Ltd. |
Poland | (L01XX05) hydroxycarbamide | Hydroxyurea medac, kaps. twarde, 500 mg | 100 szt., 500 mg , 100 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | medacGesellschaftfuerklinischeSpezialpraeparatembH |
Poland | (L02AE02) leuprorelin (adm: implant) | Librexa, implant w amp.-strzyk., 11.25 mg | 1 amp.-strzyk., 11,25 mg , 1 amp.-strzyk. 11,25 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | PrzedsiębiorstwoFarmaceutyczneLEK-AMSp.zo.o. |
Poland | (L02AE02) leuprorelin (adm: P, depot inj) | Eligard 22,5 mg, proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań, 22.5 mg | 1 zest. (tacki), 22,5 mg , 1 amp.-strzyk. z rozpuszczalnikiem | Retail price with vat |
$0-0 |
$0-0 |
n/a | RecordatiIndustriaChimicaeFarmaceuticaS.p.A |
Poland | (L02AE02) leuprorelin (adm: P, depot inj) | Eligard 45 mg, proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań, 45 mg | 1 zest. (2 strz.napeł.), 45 mg , 1 amp.-strzyk. rozpuszczalnik | Retail price with vat |
$0-0 |
$0-0 |
n/a | RecordatiIndustriaChimicaeFarmaceuticaS.p.A |
Poland | (L02AE03) goserelin (adm: implant) | Reseligo, implant w amp.-strz., 10.8 mg | 1 szt., 10,8 mg , 1 amp.-strzyk. 10,8 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
Poland | (L02AE03) goserelin (adm: implant) | Xanderla LA, implant w amp.-strz., 10.8 mg | 1 amp.-strzyk., 10,8 mg , 1 amp.-strzyk. 10,8 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsPolskaSp.zo.o. |
Poland | (L02AE03) goserelin (adm: implant) | Zoladex LA, implant podskórny, 10.8 mg | 1 amp.-strz., 10,8 mg , 1 amp.-strzyk. 10,8 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | AstraZenecaAB |
Poland | (L02AE03) goserelin (adm: implant) | Reseligo, implant w amp.-strz., 3.6 mg | 1 szt., 3,6 mg , 1 amp.-strzyk. 3,6 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
Poland | (L02AE03) goserelin (adm: implant) | Xanderla, implant w amp.-strz., 3.6 mg | 1 amp.-strzyk., 3,6 mg , 1 amp.-strzyk. 3,6 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsPolskaSp.zo.o. |